Speakers are encouraged to deliver interactive sessions by introducing multiple
choice questions (four answers only one answer is correct), clinical vignettes or
short case presentations. Theory should no represent more than 30 min of the
entire talk. Each day will last 3 hours.
Modality Online, zoom link
Dates:
- November 2nd
- November 9th
- November 16th
Time: from 15 h to 18 h CET
Language: Spanish and English (most talks will be delivered in Spanish)
SESSION 1: CLINICAL TRIALS
November 2nd, 2022
Welcome and Foreword. Ingolf Cascorbi President IUPHAR, Caroline Samer, Chair
Clinical and Translational section IUPHAR, Paula Schaiquevich, President Argentinian Society of Pharmacology, Antònia Agustì, President Spanish Society for Clinical Pharmacology
10 min
Design of clinical studies in human research. Methodology of systematic reviews and meta-
analysis.
ISMAEL ALVAREZ. HAO NIU. Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.
60 min
Early phase trials and their pitfalls. Late phase clinical trials
MAGI FARRE. Catedrático de Farmacología. Jefe de Servicio de Farmacología Clínica. Hospital Germans Trias y Pujol. Universidad Autónoma de Barcelona.
60 min
Main methodological principles in the design of a Clinical Trial
M ISABEL LUCENA. Professor of Pharmacology. Head Clinical Pharmacology Unit. Hospital Universitario Virgen de la Victoria, IBIMA-Plataforma BIONAND, UMA. Málaga, Spain
50 min
General Discussion
SESSION 2: DRUG DEVELOPMENT AND REGULATION, DRUG SAFETY
November 9th, 2022
The European Drug Regulation. Early access tools to therapeutic innovation.
ARANTXA SANCHO, Clinical Pharmacology Department. Hospital U. Puerta de Hierro Madrid, Spain. Executive Committee EACPT & SEFC
60 min
Ethical issues in drug research in humans: Human studies committees: composition and function
ENCARNACIÓN BLANCO. Profesor de Farmacología Clínica. Departamento de Farmacología. Universidad de Malaga, IBIMA, Spain
45 min
Supporting academic research and facilitating clinical trials across countries
ALBERTO M. BOROBIA, Deputy Manager of the Spanish Clinical Research Network (SCReN), Hospital La Paz, Madrid, Spain
MYRIAM ROL, European Corresponsal (EuCo) of ECRIN in Spain. European Clinical Research Infrastructure Network (ECRIN). Unidad Investigación Clínica IBIMA, Málaga, Spain
30 min
Drug safety during clinical drug development & Pharmacovigilance – yellow card scheme
JUDITH SANABRIA CABRERA. Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain
45 min
General Discussion
SESSION 3: SPECIAL POPULATIONS & PRECISION MEDICINE
November16th, 2022
Diagnosis of Drug induced liver injury: remaining challenges and new opportunities
M ISABEL LUCENA. Professor of Pharmacology. Head Clinical Pharmacology Unit. Hospital Universitario Virgen de la Victoria, IBIMA, UMA. Málaga, Spain
45 min
Precision medicine in organ transplantation
PIERRE MARQUET. President of the European Association for Clinical Pharmacology, Head of Dpt Pharmacology-toxicology University Hospital of Limoges, INSERM, France
45 min
Clinical pharmacology of special populations, with focus on children and pregnant and lactating women
FACUNDO GARCIA-BOURNISSEN. Chair, Pediatric Clinical Pharmacology Section IUPHAR. Head, Division of Paediatric Clinical Pharmacology, Dpt of Paediatrics, Schulich School of Medicine and Dentistry. Western University. London, Ontario, Canada
45 min
Drug-drug interactions. Phenotyping drug metabolism and transport
CAROLINE SAMER, Head Clinical Pharmacology and Toxicology Department, Geneva University Hospitals, Switzerland
45 min
General Discussion
